What is Next Ferm?
Next Ferm operates at the intersection of biotechnology and food science, focusing on the development of high-quality fermented vegan proteins. The company's core product portfolio, which includes ProteVin, Maximmune, AstaFerm, and NextFreeze, is engineered to address the critical challenges of taste, texture, and nutritional density in plant-based alternatives. By utilizing advanced fermentation processes, Next Ferm provides food manufacturers with functional ingredients that enhance the sensory profile of their products, effectively bridging the gap between traditional animal-based proteins and modern vegan alternatives. Their market position is defined by a commitment to innovation, aiming to set a new standard for the perfect vegan protein in an industry increasingly focused on sustainability and health-centric food solutions.
How much funding has Next Ferm raised?
Next Ferm has raised a total of $10.1M across 2 funding rounds:
Stock Offering
$9.2M
Unspecified
$918K
Stock Issuance/Offering (2021): $9.2M, investors not publicly disclosed
Unspecified (2021): $918K led by Ortal, Gadot Group, Arancia International, Cider Holdings, Orgad Agricultural Cooperative, and Merage Foundations
Key Investors in Next Ferm
Arancia International
Arancia International is a diversified group with a strong focus on value-added services, biotechnology, logistics, and energy, providing strategic institutional investments since 1925.
Gadot Group
Gadot Group is a prominent player in the food and beverage ingredient industry, specializing in the supply and distribution of high-quality nutritional solutions.
Merage Foundations
Merage Foundations is an investment entity dedicated to fostering innovation and economic growth through strategic support of emerging technology and health-focused enterprises.
What's next for Next Ferm?
Looking ahead, the strategic deployment of the $9.2M will likely focus on scaling production capacity and deepening research and development efforts. As the global demand for sustainable protein sources continues to rise, Next Ferm is poised to capitalize on its technological edge to capture a larger share of the alternative protein market. Future growth will likely involve expanding distribution channels and forging deeper partnerships with global food conglomerates seeking to improve the nutritional value of their plant-based offerings. By maintaining its focus on high-performance ingredients, the company is well-equipped to navigate the complexities of the food-tech sector and drive long-term value for its stakeholders.
See full Next Ferm company page
